CION Ameerpet
Cervical Cancer FAQ · Reviewed by CION Oncologists · NABH Accredited
How Common Is Cervical Cancer in India?
Common enough that it is consistently among the top few cancers affecting Indian women, and common enough that India accounts for roughly a fifth of the world’s cervical cancer deaths. The WHO and IARC estimate that India records well over a lakh new cases every year, and the ICMR-NCDIR National Cancer Registry Programme has for decades placed cervical cancer among the two or three commonest cancers in Indian women. But the more useful number is the one behind those: India’s share of global deaths is higher than its share of global cases, and the reason is not a shortage of treatment. It is that most Indian women have never been screened, and most are diagnosed late. This page explains what the data actually say, and what they mean for you personally.
- Among the commonest cancers in Indian women — per ICMR-NCDIR registry reporting over successive decades
- Incidence is falling, not rising — age-adjusted rates have declined across most Indian registries
- Screening coverage is the real gap — national survey data show only a small minority of eligible women have ever been tested
- It is the most preventable common cancer — a decade-long precancer window makes screening unusually effective
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What the Indian Data Actually Show
Cancer statistics in India come from two main places, and it helps to know which is which. The ICMR-NCDIR National Cancer Registry Programme compiles population-based and hospital-based registries from across the country and is the domestic source of record. The WHO/IARC GLOBOCAN programme produces modelled estimates that allow India to be compared with other countries. They are measuring slightly different things, which is why published figures differ, and why a single headline number is less useful than the pattern underneath it.
- It is one of the leading cancers in Indian women. Registry reporting has consistently placed cervical cancer among the two or three most frequently recorded cancers in women nationally, alongside breast cancer, though the ranking varies between registries and between urban and rural populations.
- India’s absolute burden is among the largest in the world. With a very large population of women in the at-risk age range, India records well over a lakh new cases a year on WHO/IARC estimates — and roughly a fifth of the world’s cervical cancer deaths.
- Deaths outweigh what the case numbers alone would predict. The gap between India’s share of global cases and its larger share of global deaths is a stage-at-diagnosis problem, not a treatment-availability problem.
- Rates are higher in rural and under-screened populations. Registries covering rural districts have generally reported higher cervical cancer rates than metropolitan registries, which mirrors differences in screening access rather than any biological difference.
- The trend over decades is downward. Age-adjusted incidence has been declining across most Indian population-based registries, a pattern attributed to improving living conditions, smaller family sizes and better gynaecological care — even before organised screening became widespread.
If you want the disease itself rather than the epidemiology, start with the cervical cancer overview hub, which covers causes, symptoms, diagnosis and treatment in sequence.
Did You Know? Cervical cancer is the only common cancer the World Health Organization has committed to eliminating as a public health problem. Its Global Strategy sets a threshold of fewer than 4 new cases per 100,000 women per year, to be reached through three targets by 2030: 90% of girls fully vaccinated against HPV by age 15, 70% of women screened with a high-performance test by 35 and again by 45, and 90% of women with cervical disease receiving treatment. No equivalent elimination target exists for any other major cancer — because no other major cancer has both a vaccine and a decade-long precancerous window. Source: WHO Global Strategy to Accelerate the Elimination of Cervical Cancer.
Why India Carries So Much of the Global Burden
None of these reasons is about Indian women being biologically more susceptible. Every one of them is a systems problem, and every one of them is fixable — which is exactly why the numbers have been improving.
The biggest factor
Very Low Screening Coverage
India’s National Family Health Survey has found that only a small minority of women aged 30 to 49 have ever undergone a cervical screening test of any kind. In countries where organised screening reached most women, cervical cancer rates fell sharply within a generation. This single gap explains more of the burden than anything else on this list.
The consequence
Late Stage at Diagnosis
Hospital-based registry data have long shown that a large proportion of Indian women are diagnosed with locally advanced disease rather than early disease. Because outcomes depend heavily on stage, late presentation converts a treatable cancer into a much harder one — and it is the main reason mortality outruns incidence.
Cultural
Stigma Around Gynaecological Symptoms
Bleeding, discharge and pain are subjects many women were raised not to discuss, including with their own families. Symptoms are frequently endured for months. This is why a woman doctor on request and a private consultation room are not a nicety — they change whether a woman comes in at all.
Structural
Access, Distance and Cost
Reaching a centre that can perform a colposcopy and a biopsy, and then deliver radiation with brachytherapy, is far easier in a metro than in a district. Distance, lost daily wages and the fear of an unpredictable bill all delay presentation, and delay is precisely what changes the outcome.
Preventive
HPV Vaccination Still Scaling Up
Almost all cervical cancer follows persistent infection with high-risk HPV, and the HPV vaccine given before exposure prevents the infections that cause most of it. Coverage in India is rising but is still far from the WHO target — and because the vaccine acts decades ahead, its effect on these statistics is only beginning.
Under-recognised
Awareness of the Long Warning Window
Most people do not know that cervical cancer takes years to develop from a precancerous change, or that early disease is usually symptomless. Women wait for a symptom that early cancer does not produce. How fast cervical cancer develops and spreads explains that timeline.
Read together, these say something hopeful: India’s cervical cancer problem is overwhelmingly a problem of detection timing, and detection timing is the one variable an individual woman can change on her own.
Who It Affects — and What “Common” Means for You
A national statistic is not a personal risk. Your own risk depends on a small number of things, most of which you can act on.
Age — a middle-age disease, with a long silent lead-in
Indian registry data show incidence climbing from the mid-thirties and peaking in middle age, with a substantial number of cases in women in their forties and fifties. The precancerous change that precedes it, though, begins much earlier and produces no symptoms, which is why screening starts long before the age at which cancer typically appears. What age cervical cancer affects covers the age question in detail.
HPV exposure — common; persistent infection — not
High-risk HPV is a very common infection, and most people clear it without ever knowing they had it. Cancer follows only when a high-risk type persists for years. That distinction matters enormously for how you should read these statistics: exposure is near-universal, disease is not. Rare cases without detectable HPV do exist — see can you get cervical cancer without HPV.
Screening history — the single strongest modifier
Across every population studied, the women who develop invasive cervical cancer are disproportionately the women who were never screened or who were screened long ago. A Pap smear primarily detects precancerous change rather than established cancer, and that is the point of it. There is no blood test that screens for cervical cancer, which is a common and costly misunderstanding.
Other factors — real, but secondary
Smoking, a weakened immune system including untreated HIV, many full-term pregnancies and long-term hormonal contraception have all been associated with higher risk. They matter, but they act on top of persistent HPV infection rather than instead of it. Cervical cancer is not an inherited disease in the way that some breast and ovarian cancers are, and having a mother or sister with it does not carry the same meaning.
The practical translation of every statistic on this page: if you are over thirty and have never had a Pap smear or an HPV test, you are in the group these numbers are actually about. If you are screened at the recommended interval, you are not. That is the whole difference, and it costs one appointment to move from one group to the other. How to prevent cervical cancer — beyond the vaccine sets out the full prevention picture.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Statistics Change One Appointment at a Time
A Pap smear and an HPV test take one visit at any of CION’s 7 NABH-accredited Hyderabad locations, with a woman doctor available on request and same-week appointments.
How to Read Cervical Cancer Statistics Without Frightening Yourself
Cancer statistics are widely misread, and cervical cancer statistics especially so. Four habits make them far more useful.
Separate absolute numbers from rates
India records a very large number of cases partly because India has a very large population. The rate — cases per 100,000 women, age-adjusted — is the figure that lets you compare places and track change over time. Headlines usually quote the absolute number, which is why coverage can suggest a worsening problem while the underlying rate is falling.
Separate incidence from mortality
Incidence is how many people get the disease; mortality is how many die of it. India’s cervical cancer mortality is high relative to its incidence, and that ratio is a statement about how late the disease is being found, not about how aggressive it is. Countries with strong screening programmes have narrowed the same ratio dramatically without changing anything about the biology of the cancer.
Remember that survival statistics are historical and grouped
Any published survival figure describes women diagnosed years ago, treated with what was available then, and averaged across every stage and every age. It is a description of a large group in the past, never a prediction about one woman in the present. Cervical cancer life expectancy — understanding the statistics works through this properly, and is stage 4 cervical cancer curable covers the question people are usually really asking.
Do not use statistics as a substitute for symptoms
Reading that cervical cancer is a middle-aged woman’s disease is not a reason for a thirty-two-year-old with bleeding after sex to wait, and reading that early disease is often painless is not a reason to ignore pain — on which, see is cervical cancer painful. Population data describe populations. Your symptoms describe you, and they always outrank a statistic.
The Questions People Search For, and What the Data Say
A quick reference. Each row is a summary, not a diagnosis, and the linked pages go into each properly.
| The question | What the evidence says | What it means for you |
|---|---|---|
| Is it common in India? | Among the leading cancers in Indian women; India holds a large share of global cases and deaths | Common enough that screening is worth doing, not so common that a symptom means cancer |
| Are cases going up? | Age-adjusted incidence has been falling across most Indian registries over recent decades | The trend is favourable; screening and vaccination accelerate it |
| Why are deaths so high? | Late stage at diagnosis, driven by very low screening coverage | Timing of detection is the variable that matters most |
| Who is most affected? | Middle-aged women, disproportionately those never screened, and rural populations | Screening history changes your risk more than anything else |
| Is it inherited? | No — almost all cases follow persistent high-risk HPV infection | Family history does not carry the meaning it does in some other cancers |
| Can men be tested for HPV? | There is no routine approved HPV screening test for men | See can men be tested for HPV |
| Is it preventable? | More preventable than any other common cancer, through vaccination and screening | Both are available in Hyderabad today, not at some future date |
If a diagnosis has already been made, the epidemiology stops being the useful page — see cervical cancer treatment in Hyderabad for what happens next.
Did You Know? National averages are not the only numbers that matter — where a woman is treated shows up in the data too. For cervical cancer, 1-year survival at CION is 83.3%, against a national figure of 67.3%. That is a one-year measure across all stages, not a promise about any individual, and the gap largely reflects stage at presentation, complete treatment delivered on schedule, and every case being planned by a multidisciplinary tumour board. Sources: CION Cancer Clinics outcome data; ICMR-NCDIR National Cancer Registry Programme.
The Cervical Cancer Questions People Ask Most
This page answers the question of how common cervical cancer is. Each guide below answers one of the other questions women and their families most often search for — directly, and in plain language.
- What age does cervical cancer affect?
- How fast does cervical cancer develop and spread?
- Can a Pap smear detect cancer, or only precancer?
- Is there a blood test for cervical cancer?
- Is stage 4 cervical cancer curable?
- Is cervical cancer painful?
- Can men be tested or treated for HPV?
- Can you get cervical cancer without HPV?
- Cervical cancer life expectancy — understanding the statistics
Why Women in Hyderabad Screen and Treat at CION
A national screening gap closes one woman at a time. The clinic should make that appointment easy to keep.
Woman doctor available on request
Pap smear and HPV test in one visit
45-minute detailed consultation
Tumour board for every cancer diagnosis
17 oncologists under one system
On-site colposcopy and biopsy
7 NABH-accredited Hyderabad locations
EMI facility & insurance accepted
4.8 / 5 Google rating
Take The Next Step
Move Yourself Out of the Statistic
The women these numbers describe are overwhelmingly the women who were never screened. One appointment is all it takes to stop being one of them.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
How Common Is Cervical Cancer in India — Frequently Asked Questions
Is cervical cancer more common in India than in other countries?
In absolute numbers, yes — India records one of the largest annual counts of cervical cancer in the world, and roughly a fifth of global cervical cancer deaths occur here, on WHO and IARC estimates. Part of that is simply population size. The more meaningful comparison is the rate, adjusted for age, and there India sits well above countries that established organised screening programmes decades ago. Those countries did not have a different virus or different biology; they had systematic screening that found precancerous change before it became cancer. That is the difference the numbers are actually measuring, and it is why screening coverage rather than incidence is the figure public health bodies track most closely.
Are cervical cancer cases in India increasing or decreasing?
Age-adjusted incidence has been declining across most Indian population-based registries over recent decades, according to ICMR-NCDIR reporting. That decline began before organised screening was widespread and is generally attributed to improving living conditions, smaller family sizes and better access to gynaecological care. The absolute number of cases can still look flat or rise in headlines, because the population of women in the at-risk age group keeps growing — which is exactly why rates rather than counts are the right measure. Expanding HPV vaccination and screening are expected to accelerate the decline further, although the vaccine acts decades ahead of the cancers it prevents.
If cervical cancer is so common, why do so few Indian women get screened?
India's National Family Health Survey has found that only a small minority of women aged 30 to 49 have ever had a cervical screening test. The reasons are practical and cultural rather than medical: many women do not know screening exists or think it is only for those with symptoms, gynaecological complaints carry real stigma, a pelvic examination feels intrusive, and reaching a centre can mean lost daily wages and an unpredictable bill. Almost all of these are addressable — a woman doctor on request, a private consultation room, both tests in one visit and a clear price quoted in advance remove most of the barriers people actually cite.
Does a high national figure mean my own risk is high?
No. A national statistic describes a population; your risk depends on your own circumstances. The strongest modifier by far is your screening history — across every population studied, invasive cervical cancer falls disproportionately on women who were never screened or were screened many years ago. Persistent high-risk HPV infection is the necessary cause, and while exposure to HPV is very common, persistence for years is not. Smoking, a weakened immune system and other factors add to risk but act on top of that infection. Being screened at the recommended interval moves you into the group these numbers are not about.
Is cervical cancer more common in Telangana or in rural areas than in Hyderabad?
Indian registries covering rural districts have generally reported higher cervical cancer rates than metropolitan registries. The difference is not biological. It tracks access to screening, distance from a centre that can perform colposcopy and biopsy, awareness, and how long symptoms are endured before a woman presents. Living in Hyderabad does not confer protection by itself — a woman in the city who has never been screened carries the risk of an unscreened woman anywhere. What a city does offer is that the appointment is easy to reach, which is precisely the advantage worth using.
Medical disclaimer: This page summarises published cervical cancer statistics for India, reviewed by a CION oncologist. Population data describe groups and cannot tell you your individual risk, and figures from different sources differ because they measure different things. If you have abnormal bleeding, unusual discharge or pelvic pain, or you are overdue for cervical screening, please see a doctor rather than relying on any website.